DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 19.115
NA - Nord America 9.609
AS - Asia 8.135
SA - Sud America 1.384
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 11
Totale 38.390
Nazione #
RU - Federazione Russa 12.411
US - Stati Uniti d'America 9.479
SG - Singapore 3.170
IE - Irlanda 1.945
CN - Cina 1.530
HK - Hong Kong 1.504
BR - Brasile 1.156
UA - Ucraina 1.100
GB - Regno Unito 935
IT - Italia 818
VN - Vietnam 772
SE - Svezia 493
DE - Germania 444
FI - Finlandia 331
KR - Corea 288
TR - Turchia 241
IN - India 197
GR - Grecia 192
FR - Francia 187
JP - Giappone 124
AR - Argentina 92
AT - Austria 76
MX - Messico 52
BD - Bangladesh 47
CA - Canada 45
EC - Ecuador 40
ZA - Sudafrica 39
NL - Olanda 38
IQ - Iraq 35
ID - Indonesia 34
PK - Pakistan 28
BE - Belgio 25
UZ - Uzbekistan 24
ES - Italia 23
VE - Venezuela 20
SA - Arabia Saudita 19
KE - Kenya 18
MA - Marocco 18
CL - Cile 17
CO - Colombia 17
PY - Paraguay 17
EU - Europa 16
PL - Polonia 15
JO - Giordania 14
EG - Egitto 12
PH - Filippine 11
AE - Emirati Arabi Uniti 10
MK - Macedonia 10
TN - Tunisia 10
UY - Uruguay 10
AU - Australia 9
DZ - Algeria 9
LT - Lituania 9
PT - Portogallo 9
AL - Albania 8
JM - Giamaica 8
PE - Perù 8
BO - Bolivia 7
KZ - Kazakistan 7
MY - Malesia 7
NP - Nepal 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
BH - Bahrain 6
CZ - Repubblica Ceca 6
LB - Libano 6
TH - Thailandia 6
TW - Taiwan 6
CH - Svizzera 5
HN - Honduras 5
IL - Israele 5
RO - Romania 5
AZ - Azerbaigian 4
IR - Iran 4
KG - Kirghizistan 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KW - Kuwait 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 38.374
Città #
Moscow 4.482
Dublin 1.940
Jacksonville 1.673
Hong Kong 1.501
Singapore 1.326
Santa Clara 1.167
Chandler 1.011
San Jose 775
Ashburn 468
Princeton 336
Roxbury 274
Seoul 272
Ho Chi Minh City 243
Hefei 213
Cambridge 207
Boardman 188
Woodbridge 171
Hanoi 169
New York 160
Beijing 157
Dallas 137
Ann Arbor 135
Medford 134
The Dalles 130
Wilmington 124
Bengaluru 96
São Paulo 88
Mountain View 85
Nuremberg 85
Des Moines 71
San Mateo 63
Naples 60
Orem 60
Nanjing 51
Da Nang 50
Munich 46
Haiphong 42
Jinan 40
Lappeenranta 39
Los Angeles 35
Milan 35
Belo Horizonte 33
Rio de Janeiro 33
Chennai 32
Marano Di Napoli 32
Frankfurt am Main 31
Vienna 29
Düsseldorf 28
Norwalk 26
Atlanta 24
Brussels 24
Council Bluffs 23
Manchester 23
Tokyo 23
Amsterdam 22
Changsha 22
Falkenstein 22
Shenyang 22
Guangzhou 21
Houston 21
Helsinki 20
Rome 20
Tashkent 20
Ninh Bình 19
Bremen 18
Johannesburg 18
London 18
Porto Alegre 18
Bologna 17
Brasília 17
Dhaka 17
Nanchang 17
Shanghai 17
Tianjin 17
Toronto 17
Brooklyn 16
Hải Dương 16
San Francisco 16
Washington 16
Kunming 15
Nairobi 15
Quito 15
Salvador 15
Amman 14
Chicago 14
Curitiba 14
Guayaquil 14
Taiyuan 14
Venice 14
Zhengzhou 14
Boston 12
Campinas 12
Hebei 12
Seattle 12
Baghdad 11
Caserta 11
Hangzhou 11
Mumbai 11
Ningbo 11
Ribeirão Preto 11
Totale 19.436
Nome #
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 256
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 186
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 173
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 163
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 163
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 162
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 162
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 158
A case of destructive infective endocarditis 150
A case of coagulopathy of unclear definition 149
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 149
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 148
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 147
Yellow nail syndrome as a cause of unexplained edema 147
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 147
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 147
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 145
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 144
The value of open-source clinical science in pandemic response: lessons from ISARIC 144
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 143
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 143
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 142
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 142
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 141
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 140
Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit 139
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 139
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 139
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 137
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 137
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 134
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 134
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 132
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 132
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 132
Emerging Concepts on Infection of Novel Cardiac Implantable Devices 131
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 131
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 131
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 130
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 130
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 130
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 129
Pharmacokinetic parameters of CAZ-AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care 129
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 129
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 128
. Iperomocisteinemia in pazienti con cardiomiopatia dilatativa: relazione con i parametri di funzione cardiaca e ruolo dei polimorfismi genici predisponenti 128
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 128
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 127
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 126
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 126
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 126
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 125
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 125
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 125
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 124
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 123
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies 122
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 122
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 121
Does this patient have COVID-19? A practical guide for the internist 121
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 120
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 120
Viral Hepatitis C 119
Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence 119
Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal 118
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 118
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 118
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 118
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 118
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 117
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 117
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 116
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 116
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 116
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 116
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 116
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 115
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 115
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview 114
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 114
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 114
Monkeypox infection: An update for the practicing physician 114
Trapianto cardiaco non complicato in paziente con infezione da HIV 113
Report on 509 defined cases of infectious endocarditis of the multicentric italian study (SEI) 113
Management of carbapenem resistant Enterobacteriaceae infections 113
Ruolo dell’asse GH/IGF-1 nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale 112
Comunicazione orale: Association of plasma homocysteine levels with infective endocarditis. 112
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 112
Mutato spettro clinico della endocardite infettiva in persone tossicodipendenti 112
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 112
Drugs and liver injury: a not to be overlooked binomial in COVID-19 112
Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review 111
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 110
Mild chronic hepatitis C with steatosis: Which treatment? 110
Caratteristiche cliniche ed esito delle infezioni di protesi vascolari: studio di una coorte prospettica 110
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 109
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 109
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis 109
High-dose daptomycin is safe and effective for cardiac implantable electronic device endocarditis. 109
Inherited thrombophilia as a risk factor for infective endocarditis on cardiac rhythm management devices 108
Totale 12.977
Categoria #
all - tutte 130.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021803 0 0 0 0 0 0 0 0 0 368 292 143
2021/20221.878 71 15 9 31 686 13 29 58 62 87 151 666
2022/20233.795 368 57 22 331 381 327 25 260 1.814 36 83 91
2023/20241.621 144 45 67 90 595 136 54 74 10 20 156 230
2024/20255.346 14 55 54 159 783 701 554 569 610 1.189 403 255
2025/202620.365 693 870 1.029 1.142 1.664 11.693 1.166 947 840 321 0 0
Totale 38.890